Ayuso T, Jericó I
Servicio de Neurología, Hosptal de Navarra, Pamplona, Spain.
An Sist Sanit Navar. 2008;31 Suppl 1:115-26.
Acute muscle weakness (AMW) is the predominant symptom of neuromuscular emergencies, especially if it affects the respiratory or oropharyngeal musculature . AMW is a multi-etiological syndrome, with different lesion levels in the motor unit. Within the broad group of neuromuscular diseases, those that most frequently provoke AMW and respiratory failure are Guillain-Barré syndrome (GBS) and myasthenia gravis (MG). GBS is the most frequent cause of acute flaccid paralysis; it can cause respiratory failure in a third of cases, making mechanical ventilation necessary. Accurate diagnosis of this syndrome enables immunomodulatory treatment to be started, which has been shown to modify the course of the disease. Besides, clinical evaluation of the patients and knowledge of the simple tests of neurophysiology and respiratory function will guide the decision on mechanical ventilation, avoiding emergency intubation. The most frequent emergency caused by MG is myasthenic crisis, defined by the deterioration in the bulbar function with acute respiratory insufficiency and risk of respiratory stoppage. This occurs in 15-20% of myasthenic patients and can be triggered by numerous factors. Besides early identification of the crisis, it is important to suppress the triggering factors and to provide measure of ventilatory support. Amongst the pharmacological measures, the most useful instruments at present are plasmapheresis and intravenous immunoglobulins; these treatments do not cancel the need for intensive vigilance and of checking for imminent signs of respiratory failure that will involve invasive or non-invasive ventilatory support.
急性肌无力(AMW)是神经肌肉急症的主要症状,尤其是当其影响呼吸或口咽肌肉组织时。AMW是一种多病因综合征,运动单位存在不同的病变水平。在众多神经肌肉疾病中,最常引发AMW和呼吸衰竭的是吉兰-巴雷综合征(GBS)和重症肌无力(MG)。GBS是急性弛缓性麻痹最常见的病因;三分之一的病例可导致呼吸衰竭,因此需要机械通气。对该综合征的准确诊断能够启动免疫调节治疗,已证明这种治疗可改变疾病进程。此外,对患者的临床评估以及对神经生理学和呼吸功能简单检查的了解将指导机械通气的决策,避免紧急插管。MG最常见的急症是肌无力危象,其定义为球部功能恶化伴急性呼吸功能不全及呼吸停止风险。这在15%至20%的重症肌无力患者中发生,可由多种因素触发。除了早期识别危象外,抑制触发因素并提供通气支持措施也很重要。在药物治疗措施中,目前最有用的手段是血浆置换和静脉注射免疫球蛋白;这些治疗并不能消除密切监测以及检查即将出现的呼吸衰竭迹象(这将涉及有创或无创通气支持)的必要性。